MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Directional steering in subthalamic deep brain stimulation for Parkinson’s disease: the Berlin experience

    V. Heinz, A. Marcelino, GH. Schneider, A. Kühn (Berlin, Germany)

    Objective: To review the use of directional current steering in a Berlin cohort implanted with segmented leads between 2016-2019. Background: The dorsolateral area of the subthalamic…
  • MDS Virtual Congress 2021

    DOPAMINERGIC AND NON-DOPAMINERGIC TREATMENT AFTER DEEP BRAIN STIMULATION (DBS) IN PARKINSON DISEASE (PD). IMPORTANCE OF NON MOTOR SYMPTOMS (NMS)

    T. Muñoz Ruiz, L. García Trujillo, G. Pons Pons, L. Romero Moreno, M. Troya Castilla, V. Fernández Sánchez, P. Serrano Castro (Málaga, Spain)

    Objective: To analyse global pharmacological adjustment after Deep Brain Stimulation (DBS) in Parkinson's Disease (PD) patients, and secondarily its relation with Non Motor Symptoms (NMS).…
  • MDS Virtual Congress 2021

    Real-world characteristics of advanced Parkinson’s disease patients initiating carbidopa/levodopa enteral suspension

    M. Soileau, I. Malaty, J. Aldred, A. Merola, R. Rodriguez, N. Gupta, I. Sultan, P. Kandukuri, Y. Jalundhwala, O. Ladhani, I. Pan, R. Pahwa (Georgetown, USA)

    Objective: To describe the real-world characteristics of advanced Parkinson’s disease (APD) patients initiating carbidopa/levodopa enteral suspension (CLES) therapy in USA Background: CLES is an FDA…
  • MDS Virtual Congress 2021

    Unusual Progressive Supranuclear Palsy: a case report

    L. Megherbi, H. Si Ahmed, S. Daoudi (Tizi Ouzou, Algeria)

    Objective: Introduction: Progressive supranuclear palsy (PSP) is a rare brain condition. It is predominantly a sporadic disease that occurs between 45 and 75 years of…
  • MDS Virtual Congress 2021

    Characteristics of daily exercise patterns in various stages of Parkinson’s disease

    J. Song, JK. Mun, JH. Ahn, J. Youn, I. Choi, JW. Cho (Seoul, Republic of Korea)

    Objective: To investigate the patterns of exercise in the daily lives of mild to severe PD patients. Background: Despite the reported clinical impact of exercise…
  • MDS Virtual Congress 2021

    Perampanel inhibits α-synuclein transmission in Parkinson’s disease models

    J. Ueda, N. Uemura, R. Takahashi (Kyoto, Japan)

    Objective: To examine the effect of perampanel, an antiepileptic drug, on α-synuclein transmission in cultured cells and mouse models of Parkinson’s disease. Background: The intercellular transmission of pathogenic proteins…
  • MDS Virtual Congress 2021

    Effects of levodopa on cognitive functions in Parkinson’s disease

    S. Ismailova, S. Prokopenko (Krasnoyarsk, Russian Federation)

    Objective: To assess the dynamics of cognitive functions (CF) under the influence of levodopa in PD patients Background: Our research is devoted to an urgent problem-the…
  • MDS Virtual Congress 2021

    The Functional Impact of REM Sleep Behavior Disorder in Parkinson’s Disease with Mild Cognitive Impairment

    R. Schade, E. Bayram (La Jolla, USA)

    Objective: This study examines whether severity and the functional impact of cognitive decline in Parkinson’s disease mild cognitive impairment (PD MCI) participants differ between those…
  • MDS Virtual Congress 2021

    Parkin Mutation and Deep Brain Stimulation

    E. Erdil, H. Omercikoglu, F. Bayraklı, D. Gunal (Istanbul, Turkey)

    Objective: To investigate the clinical features of Parkin mutated patients who undergone subthalamic brain stimulation (DBS group) and pharmalogically treated only (Non-DBS group). Background: The…
  • MDS Virtual Congress 2021

    HYPERSEXUAL DISORDER IN GBA-ASSOCIATED PARKINSON’S DISEASE: CASE REPORT

    M. Montenegro, C. Malcher, V. Cardoso, A. Escudeiro, A. Silva, B. Santos-Lobato (Belém, Brazil)

    Objective: To describe a patient with PD and hypersexual disorder carrying a GBA variant. Background: Compulsive sexual behavior occurs in 4% of patients with Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 426
  • 427
  • 428
  • 429
  • 430
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley